MISSION
Driving creative innovation to protect microvessels, overcome intractable diseases, and contribute to longer, healthier lives.
An Emerging Biotech
Targeting Microvascular Dysfunction
Through Innovation
Curacle is built on the scientific concept that
protecting
and
restoring endothelial cell function
in microvessels is fundamental to treating intractable diseases.
With this foundation, the company has developed proprietary endothelial dysfunction blockers.
This approach has been validated through more than 10 disease models and early clinical studies,
and is now advancing into diabetic complications, ocular and renal diseases, and neurovascular
disorders
such as Alzheimer's — with first-in-class pipelines actively progressing across clinical and preclinical
stages.
Curacle’s innovation is driven by
two proprietary platforms
SOLVADYS® Platform
Oral small-molecule therapeutics
EAGLES® Platform
Antibody-based biologics
Curacle is redefining therapeutic paradigms for aging-related and
chronic diseases,
leading the development of innovative medicines that enhance quality of life
and create societal value.
VISION
Leading global health innovation with breakthrough therapies and solutions that transcend the limits of intractable diseases and shape a healthier future in the aging era.